Ribomed Biotechnologies, Inc. is focused on the development of rapid, specific, and robust tests for early disease detection. Ribomed’s proprietary Abscription ® process is an extremely versatile signal generation method for the rapid, isothermal detection of RNA, DNA, and protein targets as well as DNA signatures (SNPs and CpG methylation).
